Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-49,701
Closed -$252K 339
2024
Q4
$252K Sell
49,701
-11,035
-18% -$61K 0.01% 316
2024
Q3
$418K Sell
60,736
-23,857
-28% -$141K 0.01% 353
2024
Q2
$627K Sell
84,593
-27,296
-24% -$192K 0.02% 351
2024
Q1
$817K Sell
111,889
-92,711
-45% -$793K 0.02% 295
2023
Q4
$1.27M Sell
204,600
-15,400
-7% -$69.1K 0.04% 241
2023
Q3
$898K Buy
+220,000
New +$858K 0.02% 346
2019
Q1
Sell
-258,105
Closed -$462K 19
2018
Q4
$462K Sell
258,105
-12,000
-4% -$35.3K 0.02% 200
2018
Q3
$1.18M Sell
270,105
-329,895
-55% -$1.37M 0.03% 194
2018
Q2
$2.22M Buy
+600,000
New +$2.78M 0.04% 156

Other funds holding ARDX

UBS O'Connor's ARDX Position: Q1 2025 in Review

UBS O'Connor sold out of Ardelyx (ARDX) in Q1 2025, closing a stake of 49,701 shares — an estimated $252K sold.

UBS O'Connor first reported a position in ARDX in Q2 2018 and held it in 9 quarters. The position peaked at $2.22M in Q2 2018. 221 funds tracked by Wall St. Rank hold ARDX as of Q1 2025.

  • UBS O'Connor reported no remaining Ardelyx position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 49,701 Ardelyx shares in Q1 2025, an estimated $252K.
  • UBS O'Connor first reported a position in Ardelyx in Q2 2018 and held it in 9 quarters.
  • UBS O'Connor's Ardelyx position peaked at $2.22M in Q2 2018.
  • 221 funds tracked by Wall St. Rank held Ardelyx as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.